Things They Are a Changing in the Field of Nontuberculous Mycobacteria

This issue of Clinics in Chest Medicine is dedicated to Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD). There has been an exponential increase in NTM-PD in many regions of the world over the past 20 years. The last review on Nontuberculous Mycobacteria in Clinics in Chest Medicine was published in 2015. Since that issue, we have witnessed a historical milestone in the field of NTM-PD. The first drug was approved by the FDA for the treatment of refractory Mycobacterium avium complex (MAC) pulmonary disease.
Source: Clinics in Chest Medicine - Category: Respiratory Medicine Authors: Tags: Preface Source Type: research